Stopping anticoagulants can harm A-fib patients, study finds

04/26/2012 | HealthDay News

Patients with atrial fibrillation who discontinued anticoagulant treatment were at greater risk for strokes and blood clots, according to a study from researchers at Duke University and UCLA. The risk of excessive bleeding was similar for those taking warfarin and rivaroxaban.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA